The protective effects of diltiazem were examined in a rabbit model of spinal cord ischaemia–reperfusion induced by infrarenal aortic occlusion for 30 min. In the diltiazem group (n = 6), an intravenous infusion (2 μg/kg per min) was started 10 min before ischaemia induction; normal saline solution was infused in the control group (n = 6). Neurological function was assessed using modified Tarlov criteria 24 h after surgery. Plasma samples were analysed for interleukin (IL)-6 and IL-10. Spinal tissue was analysed for malondialdehyde, nitric oxide and reduced glutathione activities. Tarlov scores of the diltiazem-treated rabbits indicated significantly improved hind-limb motor function compared with the control group. The diltiazem group also had better quantitative and qualitative histopathological findings. Diltiazem infusion significantly reduced IL-6 levels 3 and 24 h after reperfusion compared with the control group. The mean IL-10 level in the diltiazem group was significantly higher than in the control group 24 h after reperfusion. It is concluded that diltiazem has cytoprotective and anti-inflammatory properties, leading to reduced spinal cord injury.
CambriaRPDavisonJKZannettiS: Clinical experience with epidural cooling for spinal cord protection during thoracic and thoracoabdominal aneurysm repair. J Vasc Surg1997; 25: 241–243.
2.
GharagozlooFLarsonJDausmannMJ: Spinal cord protection during surgical procedures on the descending thoracic and thoracoabdominal aorta: Review of current techniques. Chest1996; 109: 799–809.
3.
StysPK: White matter injury mechanisms. Curr Mol Med2004; 4: 113–130.
4.
OuardouzMNikolaevaMACoderreE: Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors. Neuron2003; 40: 53–63.
5.
DirnaglUIadecolaCMoskowitzMA: Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci1999; 22: 391–397.
6.
ChavkoMKalincakovaKKluchovaD: Blood flow and electrolytes in spinal cord ischemia. Exp Neurol1991; 112: 299–303.
7.
RheeRYGloviczkiPCambriaRA: The effects of nimodipine on ischemic injury of the spinal cord during thoracic aortic cross-clamping. Int Angiol1996; 15: 153–161.
8.
DanielisováVChavkoM: Comparative effects of the N-methyl-d-aspartate antagonist MK-801 and the calcium channel blocker KB-2796 on neurologic and metabolic recovery after spinal cord ischemia. Exp Neurol1998; 149: 203–208.
9.
JohnsonSHKraimerJMGraeberGM: Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits. Stroke1993; 24: 1547–1553.
10.
de MolBHamerlijnckRJanssenT: Infrarenal aortic occlusion in the rabbit to assess the effect of flunarizine in the prevention of ischemic spinal cord injury. Thorac Cardiovasc Surg1991; 39: 36–39.
11.
SchittekABenninkGBCooleyDA: Spinal cord protection with intravenous nimodipine. A functional and morphologic evaluation. J Thorac Cardiovasc Surg1992; 104: 1100–1105.
12.
BurnsLHJinZBowersoxSS: The neuroprotective effects of intrathecal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia. J Vasc Surg1999; 30: 334–343.
13.
KronerASeitelbergerRSchirnhoferJ: Diltiazem during reperfusion preserves high energy phosphates by protection of mitochondrial integrity. Eur J Cardiothorac Surg2002; 21: 224–231.
14.
TakeoSTanonakaKIwaiT: Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury. Biochem Pharmacol2004; 67: 565–574.
15.
CzarnowskaEKarwatowska-ProkopczukEKurzydlowskiK: Ultrastructural study of calcium shift in ischemic/reperfused rat heart under treatment with dimethylthiourea, diltiazem and amiloride. Basic Res Cardiol1998; 93: 269–275.
16.
JaneroDRBurghardtBLopezR: Protection of cardiac membrane phospholipid against oxidative injury by calcium antagonists. Biochem Pharmacol1988; 37: 4197–4203.
17.
KollerPTBergmannSR: Reduction of lipid peroxidation in reperfused isolated rabbit hearts by diltiazem. Circ Res1989; 65: 838–846.
18.
HerzogWRVogelRASchlossbergML: Short-term low dose intracoronary diltiazem administered at the onset of reperfusion reduces myocardial infarct size. Int J Cardiol1997; 59: 21–27.
19.
IsozakiHFujiiKNomuraE: Calcium concentration in hepatocytes during liver ischaemia-reperfusion injury and the effects of diltiazem and citrate on perfused rat liver. Eur J Gastroenterol Hepatol2000; 12: 291–297.
20.
FansaIGolMNisanogluV: Does diltiazem inhibit the inflammatory response in cardiopulmonary bypass?. Med Sci Monit2003; 9: PI30–PI36.
21.
DubeyLHesongZ: Anti-inflammatory action of diltiazem in patients with unstable angina. Postgrad Med J2006; 82: 594–597.
22.
Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council: Guide for the Care and Use of Laboratory Animals. Washington: National Academy Press, 1996.
23.
HoussiauFABukasaKSindicCJ: Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol1988; 71: 320–323.
24.
BlayJYBurdinNRoussetF: Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood1993; 82: 2169–2174.
25.
DoumasBTBayseDDCarterRJ: A candidate reference method for determination of total protein in serum. I. Development and validation. Clin Chem1981; 27: 1642–1650.
CassadaDCTribbleCGLongSM: Adenosine A2A agonist reduces paralysis after spinal cord ischemia: Correlation with A2A receptor expression on motor neurons. Ann Thorac Surg2002; 74: 846–849.
28.
CaparrelliDJCattaneoSM2ndBetheaBT: Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia. Ann Thorac Surg2002; 74: 838–844.
29.
MatsushitaKWuYQiuJ: Fas receptor and neuronal cell death after spinal cord ischemia. J Neurosci2000; 20: 6879–6887.
30.
MarsalaMSorkinLSYakshTL: Transient spinal ischemia in rat: Characterization of spinal cord blood flow, extracellular amino acid release, and concurrent histopathological damage. J Cereb Blood Flow Metab1994; 14: 604–614.
31.
TomesDJAgrawalSK: Role of Na+ - Ca2+ exchanger after traumatic or hypoxic/ischemic injury to spinal cord white matter. Spine J2002; 2: 35–40.
32.
HiroseKOkajimaKTaokaY: Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg2000; 232: 272–280.
33.
ToumpoulisIKPapakostasJCMatsagasMI: Superiority of early relative to late ischemic preconditioning in spinal cord protection after descending thoracic aortic occlusion. J Thorac Cardiovasc Surg2004; 128: 724–730.
34.
RoseboroughGGaoDChenL: The mitochondrial K–ATP channel opener, diazoxide, prevents ischemia–reperfusion injury in the rabbit spinal cord. Am J Pathol2006; 168: 1443–1451.
35.
JalcPMarsalaJJalcovaH: Postischemic reperfusion causes a massive calcium overload in the myelinated spinal cord fibers. Mol Chem Neuropathol1995; 25: 143–153.
36.
SavasSDelibasNSavasC: Pentoxifylline reduces biochemical markers of ischemia–reperfusion induced spinal cord injury in rabbits. Spinal Cord2002; 40: 224–229.
37.
CassadaDCGangemiJJRiegerJM: Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord. Ann Thorac Surg2001; 72: 1245–1250.
38.
LeeCJKimKWLeeHM: The effect of thalidomide on spinal cord ischemia/reperfusion injury in a rabbit model. Spinal Cord2007; 45: 149–157.
39.
KawanishiYOkadaKTanakaH: The adverse effect of back-bleeding from lumbar arteries on spinal cord pathophysiology in a rabbit model. J Thorac Cardiovasc Surg2007; 133: 1553–1558.
40.
ShiEKazuiTJiangX: NS-7, a novel Na+/Ca2+ channel blocker, prevents neurologic injury after spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg2005; 129: 364–371.
41.
ShiEJiangXKazuiT: Controlled low-pressure perfusion at the beginning of reperfusion attenuates neurologic injury after spinal cord ischemia. J Thorac Cardiovasc Surg2007; 133: 942–948.
42.
SuzukiKKazuiTTeradaH: Experimental study on the protective effects of edaravone against ischemic spinal cord injury. J Thorac Cardiovasc Surg2005; 130: 1586–1592.
43.
TsurutaSMatsumotoMFukudaS: The effects of cyclosporin A and insulin on ischemic spinal cord injury in rabbits. Anesth Analg2006; 102: 1722–1727.
44.
de HaanPKalkmanCJUbagsLH: A comparison of the sensitivity of epidural and myogenic transcranial motor-evoked responses in the detection of acute spinal cord ischemia in the rabbit. Anesth Analg1996; 83: 1022–1027.
45.
BoyleEMJrPohlmanTHCornejoCJ: Endothelial cell injury in cardiovascular surgery: Ischemia–reperfusion. Ann Thorac Surg1996; 62: 1868–1875.
46.
SiesjoBKHuBKristianT: Is the cell death pathway triggered by the mitochondrion or the endoplasmic reticulum?. J Cereb Blood Flow Metab1999; 19: 19–26.
MauneyMCBlackbourneLHLangenburgSE: Prevention of spinal cord injury after repair of the thoracic or thoracoabdominal aorta. Ann Thorac Surg1995; 59: 245–252.
49.
OrenSGossmanEFrochlichED: Effects of calcium entry blockers on distribution of blood volume. Am J Hypertens1996; 9: 628–632.
50.
KulickDLMcIntoshNCampeseVM: Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure. Am J Cardiol1987; 59: 1138–1143.
51.
ElkayamUWeberLTorkanB: Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure. Am J Cardiol1984; 53: 1321–1325.
52.
CrenesseDTornieriKLaurensM: Diltiazem reduces apoptosis in rat hepatocytes subjected to warm hypoxia-reoxygenation. Pharmacology2002; 65: 87–95.
53.
ChinSIkedaMOzakiM: Protective effect of diltiazem on hepatic ischemia-reperfusion injury in rats by improving liver tissue blood flow. Transplant Proc2005; 37: 4556–4559.
54.
ReeceTBKernJATribbleCG: The role of pharmacology in spinal cord protection during thoracic aortic reconstruction. Semin Thorac Cardiovasc Surg2003; 15: 365–377.
55.
WanSLeClercJLVincentJL: Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation. Ann Thorac Surg1997; 63: 269–276.
